Universal Ibogaine Inc.
IBOGF
$0.065
-$0.005-7.14%
| 04/30/2024 | 01/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.41% | -8.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.41% | -8.26% | |||
| Cost of Revenue | 7.85% | -9.76% | |||
| Gross Profit | -50.27% | -4.49% | |||
| SG&A Expenses | 56.90% | 6.69% | |||
| Depreciation & Amortization | -2.15% | -1.78% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.46% | -3.57% | |||
| Operating Income | -131.57% | -14.99% | |||
| Income Before Tax | -286.09% | -7.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -286.09% | -7.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -286.09% | -7.51% | |||
| EBIT | -131.57% | -14.99% | |||
| EBITDA | -236.26% | -32.71% | |||
| EPS Basic | -144.44% | -12.50% | |||
| Normalized Basic EPS | -33.33% | -20.00% | |||
| EPS Diluted | -144.44% | -12.50% | |||
| Normalized Diluted EPS | -33.33% | -20.00% | |||
| Average Basic Shares Outstanding | 48.31% | 0.01% | |||
| Average Diluted Shares Outstanding | 48.31% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
